|
|
South Africa
|
52/7.1.3/0089.087
|
AMLODIPINE/VALSARTAN 10/160 ADCO
|
None
|
-
|
Registered
|
Details →
|
|
|
South Africa
|
50/7.1.3/0852
|
AMLODIPINE/VALSARTAN 10/160 BIOTECH
|
None
|
-
|
Registered
|
Details →
|
|
|
South Africa
|
52/7.1.3/0088.086
|
AMLODIPINE/VALSARTAN 5/160 ADCO
|
None
|
-
|
Registered
|
Details →
|
|
|
South Africa
|
50/7.1.3/0851
|
AMLODIPINE/VALSARTAN 5/160 BIOTECH
|
None
|
-
|
Registered
|
Details →
|
|
|
Kenya
|
17849
|
EXFORGE TABLETS 5/160MG
|
AMLODIPINE/VALSARTAN
|
NVS KENYA LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2007/17849/R1
|
Exforge tablets 5/160mg
|
Amlodipine/valsartan
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
Kenya
|
17850
|
EXFORGE TABLETS 10/160MG
|
AMLODIPINE/VALSARTAN
|
NVS KENYA LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2007/17850/R1
|
Exforge tablets 10/160mg
|
Amlodipine/Valsartan
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
Ghana
|
FDA/SD.233-030368
|
TRIVALAM H TABLETS
|
AMLODIPINE/VALSARTAN/HYDROCHLOTHIAZIDE
|
GRACURE PHARMACEUTICALS LTD
|
Valid
|
Details →
|
|
|
Kenya
|
21440
|
EXFORGE HCT TABLETS 5MG/160MG/12.5MG
|
AMLODIPINE/VALSARTAN/HYDROCHLORTHIAZIDE
|
NVS KENYA LTD
|
Registered
|
Details →
|
|
|
Kenya
|
21440/R1
|
Exforge HCT tablets 5mg/160mg/12.5mg
|
Amlodipine/valsartan/Hydrochlorthiazide
|
Novartis
|
Retained
|
Details →
|
|
|
Kenya
|
H2010/21440/538/R1
|
Exforge HCT tablets 5mg/160mg/12.5mg
|
Amlodipine/valsartan/Hydrochlorthiazide
|
Novartis
|
Retained
|
Details →
|
|
|
Kenya
|
21441
|
EXFORGE HCT TABLETS 10MG/160MG/12.5MG
|
AMLODIPINE/VALSARTAN/HYDROCHLORTHIAZIDE
|
NVS KENYA LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2010/21441/537/R1
|
EXFORGE HCT TABLETS 10MG/160MG/12.5MG
|
AMLODIPINE/VALSARTAN/HYDROCHLORTHIAZIDE
|
NVS KENYA LTD
|
Registered
|
Details →
|
|
|
Ghana
|
FDA/SD.255-122331
|
AMLOVAS 10mg/160mg TABLETS
|
(Each tablet contains Amlodipine/Valsartan – 10mg/160mg)
|
MADRAS PHARMACEUTICAL 137-B old Mahabalipuram Road, Karapakkam, Chennai – 600 096 India
|
Valid
|
Details →
|